Page 5 - Pharma Stocks

BSE Healthcare index hits record high on the back of positive news flow

The S&P BSE Healthcare index, the top gainer among sectoral indices, rose 3.5 per cent to close at 20,405 points, as compared to 0.34 per cent decline in the Sensex

Alembic gains 31% so far in September on stake purchase by promoter

As of June 30, 2020, the total promoter holding in Alembic stood at 69.57 per cent, up 195 basis points (bps) from 67.62 per cent at the end of March quarter.

Vaccine majors see sharp rally with some players rising more than 4,000%

The Indian pharmaceutical sector has also been going through a surge

New launches in key categories to trigger AstraZeneca Pharma's growth

Higher share of patented products, scope for margin improvement and chronic portfolio are key positives

Demand recovery, resumption of ops to offset weak Q1 for Jubilant Life

Growth pickup and lower debt could improve its valuations

AstraZeneca Pharma hits fresh record high of Rs 4,489; stock surges 15%

The stock of the company was trading higher for the fifth straight day, surging 26 per cent during the period.

AstraZeneca Pharma India hits fresh record high, up 15% in 8 trading days

AstraZeneca Plc, the company's parent firm, is expected to release initial data on whether a vaccine can stop people from getting the virus on September 15

Sun Pharma surges 4%, hits 52-week high; stock rallies 76% from March-low

For the quarter ended June 2020, Sun Pharma reported a surprise loss due to one-time charges.

Nifty Pharma index rallies nearly 3%; Lupin surges 10%, Cipla, Cadila up 3%

All the 10 constituents of the Nifty Pharma index were trading in the green.

Market looks expensive as earnings are likely to dip in FY21: Mihir Vora

This flood in global liquidity allows us the luxury to look beyond the immediate future i.e. FY21 and focus beyond i.e. FY22.

Covid-19: Moderna soars 18% as vaccine gives promising early results

The US biotech firm's breakthrough is one of the most promising developments yet in the race to develop a vaccine against the virus that has paralysed the world's economy.

Green shoots seen in June pharma sales as domestic market grows 2.4%

The turn around follows deep decline in sales in the preceding months; July sales likely to be flat

This pharma stock zooms over 100% in 18 trading days

The stock hit a new high of Rs 723 during the day, up 16 per cent.

Pharma shares gain; Biocon, Granules hit record highs, Sun Pharma up 3%

At 10:27 am, Nifty Pharma index was up 1.5 per cent, as compared to 0.22 per cent decline in the benchmark Nifty50 index

Mid, small-cap pharma stocks rally; Dishman Carbogen, Unichem Labs soar 20%

Panacea Biotec, Nectar Lifesciences, and Vimta Labs, too, were frozen at 20 per cent upper circuit on the BSE.

Strong Q4 performance, debt reduction show Aurobindo Pharma in good health

Despite an over 150 per cent rise since March lows, the stock can see more gains

Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018

Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.

Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%

At present there are three clinical trials underway to test nafamostat in Covid19 patients around the world

Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high

Dr Reddy's, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.

Sun Pharma's Q4 pre-tax profit down 17% at Rs 577 cr on multiple one-offs

Revenues in the US market, its largest geography, came in at $375 million down 15 per cent, though the year ago period had a high base due to a one-time contribution of specialty products